help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 59, No. 4 622-624
doi:10.1210/jcem-59-4-622
Copyright © 1984 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAWRENCE, A. M.
Right arrow Articles by HAGEN, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAWRENCE, A. M.
Right arrow Articles by HAGEN, T. C.

Chronic Propranolol Administration Impairs Glucagon Release during Insulin-Induced Hypoglycemia in Normal Man*

A. M. LAWRENCE, K. AJLOUNI{dagger} and T. C. HAGEN

Departments of Medicine, Loyola University Stritch School of Medicine Maywood, Illinois 60153 Hines Veterans Administration Hospital Hines, Illinois 60141 Wood Veterans Administration Medical Center, The Medical College of Wisconsin Milwaukee, Wisconsin 53193

Address requests for reprints to: A. M. Lawrence, M.D., Ph.D., Veterans Administration Hospital, Building 1, Room C-344, Hines, Illinois 60141.

Failure of a plasma glucagon rise in response to insulin-induced hypoglycemia was demonstrated in normal subjects taking therapeutic doses of the nonselective β-adrenergic blocker, propranolol, for 7 days before testing. This is the first study to examine glucose homeostasis in normal subjects exposed to chronic propranolol therapy and helps to explain the development of spontaneous hypoglycemia in patients, either diabetic or nondiabetic, during β-adrenergic receptor blockade. Previous studies of the acute parenteral effects of propranolol administration failed to show any significant effect on glucagon secretory dynamics in response to insulin-induced hypoglycemia. In the present study, however, chronic oral administration of propranolol resulted in severe impairment of the expected glucagon rise in response to hypoglycemia and was associated with severe hypoglycemia in one normal subject.

* This work was supported by The Veterans Administration.

{dagger} Current address: Department of Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan.

Received September 28, 1983.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society